Advancing Cancer Screening in Slovenia: A Pathw...

By HEOR Staff Writer

February 16, 2026

Spotlight on Cancer Screening Slovenia at Strategic Conference Cancer screening Slovenia took center stage at Slovenia’s 6th Strategic Conference "Living with Cancer," h...
Late-Breaking Data on Bladder Cancer Treatments from KEYNOTE-B15 Trial
AstraZeneca Financial Results: Strong Revenue Growth and Pipeline Expansion i...
KEYTRUDA Ovarian Cancer Treatments: FDA Approves New Regimens for Platinum-Re...
Enhancing Early-Stage Cancer Treatment: Overcoming Barriers for Better Outcomes
Tislelizumab NSCLC Inclusion Recommended for Dutch Health Package
Datroway Metastatic Breast Cancer: FDA Grants Priority Review for Breakthroug...
CHMP January 2026 Approvals: Expanding Access to Innovative Therapies
Latin America Pharma Growth: Boehringer Ingelheim’s Strategic Investmen...
NICE Endorses Talazoparib Enzalutamide for Prostate Cancer Treatment
Johnson & Johnson’s EMA Application for Teclistamab Daratumumab Th...
Accelerating Tec-Dara Multiple Myeloma Therapy Review: A Game Changer for Pat...
CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals